Who owns Chemomab Therapeutics Ltd.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of CMMB from SEC Form 13F filings across 13 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 13 institutions disclosed 379,833 shares of Chemomab Therapeutics Ltd. worth $615,329 — about 4.7% of shares outstanding; the largest disclosed holder is CITADEL ADVISORS LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
13
13F holders
$615,329
value, 2026 filers
4.7%
of shares outstanding (379,833 sh)
1
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of CMMB's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | 95,311 | $154,404 | 0.0% | 1.2% | +48.5% |
| 2 | ADAR1 Capital Management, LLC | 80,000 | $129,600 | 0.0% | 1% | 0.0% |
| 3 | KESTRA PRIVATE WEALTH SERVICES, LLC | 61,710 | $99,970 | 0.0% | 0.8% | 0.0% |
| 4 | Ikarian Capital, LLC | 51,793 | $83,904 | 0.0% | 0.6% | 0.0% |
| 5 | RHUMBLINE ADVISERS | 30,529 | $49,457 | 0.0% | 0.4% | +66.2% |
| 6 | XTX Topco Ltd | 15,987 | $25,899 | 0.0% | 0.2% | -14.2% |
| 7 | Philadelphia Investment Partners, LLC | 15,000 | $24,300 | 0.0% | 0.2% | +82.9% |
| 8 | Lido Advisors, LLCNEW | 14,341 | $23,232 | 0.0% | 0.2% | new |
| 9 | BNP PARIBAS FINANCIAL MARKETS | 6,805 | $11,024 | 0.0% | 0.1% | -19.2% |
| 10 | GAMMA Investing LLC | 4,740 | $7,679 | 0.0% | 0.1% | -37.5% |
| 11 | MORGAN STANLEY | 3,575 | $5,792 | 0.0% | 0% | -21.9% |
| 12 | SBI Securities Co., Ltd. | 34 | $55 | 0.0% | 0% | +21.4% |
| 13 | Caitong International Asset Management Co., Ltd | 8 | $13 | 0.0% | 0% | 0.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.